Animal studies showed that inhibiting the activity of IL-1β benefited the severity and mortality of acute pancreatitis (3), whereas overexpression of IL-1β induced the development of chronic pancreatitis (4). The gene discussed is IL1B; the disease is acute pancreatitis.